Compare AURA & TACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AURA | TACH |
|---|---|---|
| Founded | 2007 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 419.5M | 356.0M |
| IPO Year | 2021 | N/A |
| Metric | AURA | TACH |
|---|---|---|
| Price | $6.97 | $10.32 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $19.00 | N/A |
| AVG Volume (30 Days) | ★ 309.2K | 20.4K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $39.02 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.73 | $10.03 |
| 52 Week High | $7.68 | $10.38 |
| Indicator | AURA | TACH |
|---|---|---|
| Relative Strength Index (RSI) | 53.28 | 51.20 |
| Support Level | $5.94 | $10.27 |
| Resistance Level | $7.04 | $10.34 |
| Average True Range (ATR) | 0.33 | 0.02 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 35.78 | 57.14 |
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
Titan Acquisition Corp is a blank check company.